PubMed:7738013
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-51 | Sentence | denotes | Mouse interleukin-2 receptor alpha gene expression. |
| T2 | 52-139 | Sentence | denotes | Interleukin-1 and interleukin-2 control transcription via distinct cis-acting elements. |
| T3 | 140-293 | Sentence | denotes | We have shown that interleukin-1 (IL-1) and IL-2 control IL-2 receptor alpha (IL-2R alpha) gene transcription in CD4-CD8- murine T lymphocyte precursors. |
| T4 | 294-449 | Sentence | denotes | Here we map the cis-acting elements that mediate interleukin responsiveness of the mouse IL-2R alpha gene using a thymic lymphoma-derived hybridoma (PC60). |
| T5 | 450-545 | Sentence | denotes | The transcriptional response of the IL-2R alpha gene to stimulation by IL-1 + IL-2 is biphasic. |
| T6 | 546-684 | Sentence | denotes | IL-1 induces a rapid, protein synthesis-independent appearance of IL-2R alpha mRNA that is blocked by inhibitors of NF-kappa B activation. |
| T7 | 685-848 | Sentence | denotes | It also primes cells to become IL-2 responsive and thereby prepares the second phase, in which IL-2 induces a 100-fold further increase in IL-2R alpha transcripts. |
| T8 | 849-1076 | Sentence | denotes | Transient transfection experiments show that several elements in the promoter-proximal region of the IL-2R alpha gene contribute to IL-1 responsiveness, most importantly an NF-kappa B site conserved in the human and mouse gene. |
| T9 | 1077-1213 | Sentence | denotes | IL-2 responsiveness, on the other hand, depends on a 78-nucleotide segment 1.3 kilobases upstream of the major transcription start site. |
| T10 | 1214-1395 | Sentence | denotes | This segment functions as an IL-2-inducible enhancer and lies within a region that becomes DNase I hypersensitive in normal T cells in which IL-2R alpha expression has been induced. |
| T11 | 1396-1469 | Sentence | denotes | IL-2 responsiveness requires three distinct elements within the enhancer. |
| T12 | 1470-1529 | Sentence | denotes | Two of these are potential binding sites for STAT proteins. |
| T1 | 0-51 | Sentence | denotes | Mouse interleukin-2 receptor alpha gene expression. |
| T2 | 52-139 | Sentence | denotes | Interleukin-1 and interleukin-2 control transcription via distinct cis-acting elements. |
| T3 | 140-293 | Sentence | denotes | We have shown that interleukin-1 (IL-1) and IL-2 control IL-2 receptor alpha (IL-2R alpha) gene transcription in CD4-CD8- murine T lymphocyte precursors. |
| T4 | 294-449 | Sentence | denotes | Here we map the cis-acting elements that mediate interleukin responsiveness of the mouse IL-2R alpha gene using a thymic lymphoma-derived hybridoma (PC60). |
| T5 | 450-545 | Sentence | denotes | The transcriptional response of the IL-2R alpha gene to stimulation by IL-1 + IL-2 is biphasic. |
| T6 | 546-684 | Sentence | denotes | IL-1 induces a rapid, protein synthesis-independent appearance of IL-2R alpha mRNA that is blocked by inhibitors of NF-kappa B activation. |
| T7 | 685-848 | Sentence | denotes | It also primes cells to become IL-2 responsive and thereby prepares the second phase, in which IL-2 induces a 100-fold further increase in IL-2R alpha transcripts. |
| T8 | 849-1076 | Sentence | denotes | Transient transfection experiments show that several elements in the promoter-proximal region of the IL-2R alpha gene contribute to IL-1 responsiveness, most importantly an NF-kappa B site conserved in the human and mouse gene. |
| T9 | 1077-1213 | Sentence | denotes | IL-2 responsiveness, on the other hand, depends on a 78-nucleotide segment 1.3 kilobases upstream of the major transcription start site. |
| T10 | 1214-1395 | Sentence | denotes | This segment functions as an IL-2-inducible enhancer and lies within a region that becomes DNase I hypersensitive in normal T cells in which IL-2R alpha expression has been induced. |
| T11 | 1396-1469 | Sentence | denotes | IL-2 responsiveness requires three distinct elements within the enhancer. |
| T12 | 1470-1529 | Sentence | denotes | Two of these are potential binding sites for STAT proteins. |
Glycosmos6-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 927-935 | http://purl.obolibrary.org/obo/MAT_0000491 | denotes | proximal |
| T2 | 1111-1115 | http://purl.obolibrary.org/obo/MAT_0000091 | denotes | hand |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-39 | DNA | denotes | Mouse interleukin-2 receptor alpha gene |
| T2 | 52-65 | protein | denotes | Interleukin-1 |
| T3 | 70-83 | protein | denotes | interleukin-2 |
| T4 | 119-138 | DNA | denotes | cis-acting elements |
| T5 | 159-172 | protein | denotes | interleukin-1 |
| T6 | 174-178 | protein | denotes | IL-1 |
| T7 | 184-188 | protein | denotes | IL-2 |
| T8 | 197-235 | DNA | denotes | IL-2 receptor alpha (IL-2R alpha) gene |
| T9 | 253-292 | cell_line | denotes | CD4-CD8- murine T lymphocyte precursors |
| T10 | 310-329 | DNA | denotes | cis-acting elements |
| T11 | 377-399 | DNA | denotes | mouse IL-2R alpha gene |
| T12 | 408-441 | cell_line | denotes | thymic lymphoma-derived hybridoma |
| T13 | 443-447 | cell_line | denotes | PC60 |
| T14 | 486-502 | DNA | denotes | IL-2R alpha gene |
| T15 | 521-525 | protein | denotes | IL-1 |
| T16 | 528-532 | protein | denotes | IL-2 |
| T17 | 546-550 | protein | denotes | IL-1 |
| T18 | 612-628 | RNA | denotes | IL-2R alpha mRNA |
| T19 | 662-672 | protein | denotes | NF-kappa B |
| T20 | 716-720 | protein | denotes | IL-2 |
| T21 | 780-784 | protein | denotes | IL-2 |
| T22 | 824-847 | RNA | denotes | IL-2R alpha transcripts |
| T23 | 918-942 | DNA | denotes | promoter-proximal region |
| T24 | 950-966 | DNA | denotes | IL-2R alpha gene |
| T25 | 981-985 | protein | denotes | IL-1 |
| T26 | 1022-1037 | DNA | denotes | NF-kappa B site |
| T27 | 1055-1075 | DNA | denotes | human and mouse gene |
| T28 | 1077-1081 | protein | denotes | IL-2 |
| T29 | 1130-1151 | DNA | denotes | 78-nucleotide segment |
| T30 | 1182-1212 | DNA | denotes | major transcription start site |
| T31 | 1243-1266 | DNA | denotes | IL-2-inducible enhancer |
| T32 | 1305-1312 | protein | denotes | DNase I |
| T33 | 1338-1345 | cell_type | denotes | T cells |
| T34 | 1355-1366 | protein | denotes | IL-2R alpha |
| T35 | 1396-1400 | protein | denotes | IL-2 |
| T36 | 1440-1448 | DNA | denotes | elements |
| T37 | 1460-1468 | DNA | denotes | enhancer |
| T38 | 1515-1528 | protein | denotes | STAT proteins |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 52-65 | NP | denotes | Interleukin-1 |
| C2 | 70-83 | NP | denotes | interleukin-2 |
| C3 | 159-179 | NP | denotes | interleukin-1 (IL-1) |
| C4 | 184-188 | NP | denotes | IL-2 |
| C5 | 306-329 | NP | denotes | the cis-acting elements |
| C6 | 330-334 | NP | denotes | that |
| C7 | 373-399 | NP | denotes | the mouse IL-2R alpha gene |
| C8 | 482-502 | NP | denotes | the IL-2R alpha gene |
| C9 | 521-525 | NP | denotes | IL-1 |
| C10 | 528-532 | NP | denotes | IL-2 |
| C11 | 546-550 | NP | denotes | IL-1 |
| C12 | 612-628 | NP | denotes | IL-2R alpha mRNA |
| C13 | 629-633 | NP | denotes | that |
| C14 | 685-687 | NP | denotes | It |
| C15 | 716-720 | NP | denotes | IL-2 |
| C16 | 753-769 | NP | denotes | the second phase |
| C17 | 774-779 | NP | denotes | which |
| C18 | 780-784 | NP | denotes | IL-2 |
| C19 | 946-966 | NP | denotes | the IL-2R alpha gene |
| C25 | 1077-1096 | NP | denotes | IL-2 responsiveness |
| C20 | 1243-1248 | NP | denotes | IL-2- |
| C27 | 1240-1266 | NP | denotes | an IL-2-inducible enhancer |
| C21 | 1283-1291 | NP | denotes | a region |
| C22 | 1292-1296 | NP | denotes | that |
| C23 | 1331-1345 | NP | denotes | normal T cells |
| C24 | 1349-1354 | NP | denotes | which |
| C26 | 1396-1415 | NP | denotes | IL-2 responsiveness |
| C28 | 1456-1468 | NP | denotes | the enhancer |
| C29 | 1425-1468 | NP | denotes | three distinct elements within the enhancer |
| C30 | 1477-1482 | NP | denotes | these |
| C31 | 1470-1482 | NP | denotes | Two of these |
| R1 | C3 | C1 | coref-ident | interleukin-1 (IL-1),Interleukin-1 |
| R2 | C4 | C2 | coref-ident | IL-2,interleukin-2 |
| R3 | C6 | C5 | coref-relat | that,the cis-acting elements |
| R4 | C8 | C7 | coref-ident | the IL-2R alpha gene,the mouse IL-2R alpha gene |
| R5 | C9 | C3 | coref-ident | IL-1,interleukin-1 (IL-1) |
| R6 | C10 | C4 | coref-ident | IL-2,IL-2 |
| R7 | C11 | C9 | coref-ident | IL-1,IL-1 |
| R8 | C13 | C12 | coref-relat | that,IL-2R alpha mRNA |
| R9 | C14 | C11 | coref-pron | It,IL-1 |
| R10 | C15 | C10 | coref-ident | IL-2,IL-2 |
| R11 | C17 | C16 | coref-relat | which,the second phase |
| R12 | C18 | C15 | coref-ident | IL-2,IL-2 |
| R13 | C19 | C8 | coref-ident | the IL-2R alpha gene,the IL-2R alpha gene |
| R14 | C20 | C18 | coref-ident | IL-2-,IL-2 |
| R15 | C22 | C21 | coref-relat | that,a region |
| R16 | C24 | C23 | coref-relat | which,normal T cells |
| R17 | C26 | C25 | coref-ident | IL-2 responsiveness,IL-2 responsiveness |
| R18 | C28 | C27 | coref-ident | the enhancer,an IL-2-inducible enhancer |
| R19 | C30 | C29 | coref-pron | these,three distinct elements within the enhancer |
| R20 | C31 | C29 | coref-part-whole | Two of these,three distinct elements within the enhancer |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-51 | Sentence | denotes | Mouse interleukin-2 receptor alpha gene expression. |
| S2 | 52-139 | Sentence | denotes | Interleukin-1 and interleukin-2 control transcription via distinct cis-acting elements. |
| S3 | 140-293 | Sentence | denotes | We have shown that interleukin-1 (IL-1) and IL-2 control IL-2 receptor alpha (IL-2R alpha) gene transcription in CD4-CD8- murine T lymphocyte precursors. |
| S4 | 294-449 | Sentence | denotes | Here we map the cis-acting elements that mediate interleukin responsiveness of the mouse IL-2R alpha gene using a thymic lymphoma-derived hybridoma (PC60). |
| S5 | 450-545 | Sentence | denotes | The transcriptional response of the IL-2R alpha gene to stimulation by IL-1 + IL-2 is biphasic. |
| S6 | 546-684 | Sentence | denotes | IL-1 induces a rapid, protein synthesis-independent appearance of IL-2R alpha mRNA that is blocked by inhibitors of NF-kappa B activation. |
| S7 | 685-848 | Sentence | denotes | It also primes cells to become IL-2 responsive and thereby prepares the second phase, in which IL-2 induces a 100-fold further increase in IL-2R alpha transcripts. |
| S8 | 849-1076 | Sentence | denotes | Transient transfection experiments show that several elements in the promoter-proximal region of the IL-2R alpha gene contribute to IL-1 responsiveness, most importantly an NF-kappa B site conserved in the human and mouse gene. |
| S9 | 1077-1213 | Sentence | denotes | IL-2 responsiveness, on the other hand, depends on a 78-nucleotide segment 1.3 kilobases upstream of the major transcription start site. |
| S10 | 1214-1395 | Sentence | denotes | This segment functions as an IL-2-inducible enhancer and lies within a region that becomes DNase I hypersensitive in normal T cells in which IL-2R alpha expression has been induced. |
| S11 | 1396-1469 | Sentence | denotes | IL-2 responsiveness requires three distinct elements within the enhancer. |
| S12 | 1470-1529 | Sentence | denotes | Two of these are potential binding sites for STAT proteins. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-5 | DNA_domain_or_region | denotes | Mouse |
| T2 | 6-19 | protein_molecule | denotes | interleukin-2 |
| T3 | 52-65 | protein_molecule | denotes | Interleukin-1 |
| T4 | 70-83 | protein_molecule | denotes | interleukin-2 |
| T5 | 119-138 | DNA_family_or_group | denotes | cis-acting elements |
| T6 | 159-172 | protein_molecule | denotes | interleukin-1 |
| T7 | 174-178 | protein_molecule | denotes | IL-1 |
| T8 | 184-188 | protein_molecule | denotes | IL-2 |
| T9 | 197-216 | protein_molecule | denotes | IL-2 receptor alpha |
| T10 | 218-229 | protein_molecule | denotes | IL-2R alpha |
| T11 | 253-292 | cell_line | denotes | CD4-CD8- murine T lymphocyte precursors |
| T12 | 310-329 | DNA_family_or_group | denotes | cis-acting elements |
| T13 | 377-394 | protein_molecule | denotes | mouse IL-2R alpha |
| T14 | 408-441 | cell_line | denotes | thymic lymphoma-derived hybridoma |
| T15 | 443-447 | cell_line | denotes | PC60 |
| T16 | 486-502 | DNA_domain_or_region | denotes | IL-2R alpha gene |
| T17 | 521-525 | protein_molecule | denotes | IL-1 |
| T18 | 528-532 | protein_molecule | denotes | IL-2 |
| T19 | 546-550 | protein_molecule | denotes | IL-1 |
| T20 | 568-608 | other_name | denotes | protein synthesis-independent appearance |
| T21 | 612-623 | protein_molecule | denotes | IL-2R alpha |
| T22 | 662-672 | protein_molecule | denotes | NF-kappa B |
| T23 | 716-720 | protein_molecule | denotes | IL-2 |
| T24 | 780-784 | protein_molecule | denotes | IL-2 |
| T25 | 824-835 | protein_molecule | denotes | IL-2R alpha |
| T26 | 849-883 | other_name | denotes | Transient transfection experiments |
| T27 | 918-942 | DNA_domain_or_region | denotes | promoter-proximal region |
| T28 | 950-961 | protein_molecule | denotes | IL-2R alpha |
| T29 | 981-985 | protein_molecule | denotes | IL-1 |
| T30 | 1022-1032 | protein_molecule | denotes | NF-kappa B |
| T31 | 1077-1081 | protein_molecule | denotes | IL-2 |
| T32 | 1130-1151 | DNA_domain_or_region | denotes | 78-nucleotide segment |
| T33 | 1182-1212 | DNA_domain_or_region | denotes | major transcription start site |
| T34 | 1243-1266 | DNA_domain_or_region | denotes | IL-2-inducible enhancer |
| T35 | 1305-1312 | protein_molecule | denotes | DNase I |
| T36 | 1338-1345 | cell_type | denotes | T cells |
| T37 | 1355-1366 | protein_molecule | denotes | IL-2R alpha |
| T38 | 1396-1400 | protein_molecule | denotes | IL-2 |
| T39 | 1440-1448 | DNA_domain_or_region | denotes | elements |
| T40 | 1460-1468 | DNA_domain_or_region | denotes | enhancer |
| T41 | 1515-1528 | protein_family_or_group | denotes | STAT proteins |
Anatomy-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 927-935 | Body_part | denotes | proximal | http://purl.obolibrary.org/obo/MAT_0000491 |
| T2 | 1111-1115 | Body_part | denotes | hand | http://purl.obolibrary.org/obo/MAT_0000091 |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 415-423 | Phenotype | denotes | lymphoma | HP:0002665 |
| T2 | 1313-1327 | Phenotype | denotes | hypersensitive | HP:0041092 |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 408-423 | Disease | denotes | thymic lymphoma | http://purl.obolibrary.org/obo/MONDO_0000951 |
| T2 | 1313-1327 | Disease | denotes | hypersensitive | http://purl.obolibrary.org/obo/MONDO_0000605 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 0-5 | OrganismTaxon | denotes | Mouse | 10088|10090 |
| T3 | 377-382 | OrganismTaxon | denotes | mouse | 10088|10090 |
| T5 | 1055-1060 | OrganismTaxon | denotes | human | 9606 |
| T6 | 1065-1070 | OrganismTaxon | denotes | mouse | 10088|10090 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 269-281 | Body_part | denotes | T lymphocyte | http://purl.obolibrary.org/obo/CL_0000084 |
| T2 | 1111-1115 | Body_part | denotes | hand | http://purl.obolibrary.org/obo/UBERON_0002398 |
| T3 | 1144-1151 | Body_part | denotes | segment | http://purl.obolibrary.org/obo/UBERON_0000914 |
| T4 | 1219-1226 | Body_part | denotes | segment | http://purl.obolibrary.org/obo/UBERON_0000914 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 269-281 | Cell | denotes | T lymphocyte | http://purl.obolibrary.org/obo/CL:0000084 |
| T2 | 271-281 | Cell | denotes | lymphocyte | http://purl.obolibrary.org/obo/CL:0000542 |
| T3 | 1338-1345 | Cell | denotes | T cells | http://purl.obolibrary.org/obo/CL:0000084 |